| Abstrakt: |
Seattle, State:Washington, United States, North and Central America, Bioengineering, Biotechnology, Drugs and Therapies, Gene Therapy, HIV/AIDS, Health and Medicine, Immune System Diseases and Conditions, Microbiological Techniques, Primate Lentiviruses, RNA Viruses, Retroviridae, Vertebrate Viruses, Viral Load, Viral Sexually Transmitted Diseases and Conditions, Virus Physiological Phenomena The news reporters obtained a quote from the research from the University of Washington, "In vivo HSC transduc-tion/selection resulted in stable serum eCD4-Ig levels of X100 mg/mL (mice) and >20 mg/mL (rhesus) with half maximal inhibitory concentrations (IC50s) of 1 mg/mL measured by an HIV neutralization assay. Keywords: Seattle; State:Washington; United States; North and Central America; Bioengineering; Biotechnology; Drugs and Therapies; Gene Therapy; HIV/AIDS; Health and Medicine; Immune System Diseases and Conditions; Microbiological Techniques; Primate Lentiviruses; RNA Viruses; Retroviridae; Vertebrate Viruses; Viral Load; Viral Sexually Transmitted Diseases and Conditions; Virus Physiological Phenomena EN Seattle State:Washington United States North and Central America Bioengineering Biotechnology Drugs and Therapies Gene Therapy HIV/AIDS Health and Medicine Immune System Diseases and Conditions Microbiological Techniques Primate Lentiviruses RNA Viruses Retroviridae Vertebrate Viruses Viral Load Viral Sexually Transmitted Diseases and Conditions Virus Physiological Phenomena 93 93 1 06/05/23 20230605 NES 230605 2023 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators discuss new findings in Immune System Diseases and Conditions - HIV/AIDS. [Extracted from the article] |
